Skip to content
Screener

Allarity Therapeutics, Inc. ALLR Q4 2025 Annual earnings

Reported March 31, 2026

Revenue$320.0KIn line
EPS-$0.19Beat by $0.03
Revenue estimate$320.0K
EPS estimate-$0.22

Next report

Nov 13, 2026 (in 2 months)
EPS estimate-$0.25

FAQ

When did Allarity Therapeutics, Inc. report Q4 2025 earnings?
Allarity Therapeutics, Inc. (ALLR) reported Q4 2025 earnings on March 31, 2026.
What were Allarity Therapeutics, Inc.'s Q4 2025 revenue and EPS?
Allarity Therapeutics, Inc. reported revenue of $320.0K and eps of $-0.19 for Q4 2025.
Did Allarity Therapeutics, Inc. beat estimates in Q4 2025?
Revenue beat the consensus estimate of $320.0K by -. EPS beat the consensus estimate of $-0.22 by $0.03.
How did Allarity Therapeutics, Inc.'s Q4 2025 results compare year-over-year?
Compared to the same quarter a year prior, revenue grew 5233.3% from $6.0K a year earlier and eps grew 96.0% from $-4.73.
Where can I find Allarity Therapeutics, Inc.'s Q4 2025 SEC filings?
You can read the 8-K earnings release (0001213900-26-038061) and the 10-K periodic report (0001437749-26-010310) directly on SEC EDGAR. The filing index links above go to sec.gov.